Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
The Lancet. Rheumatology|January 24, 2024
Risk of admission to hospital for serious infection after initiating tofacitinib versus biologic DMARDs in patients with rheumatoid arthritis: a multidatabase cohort studyAjinkya Pawar, Rishi J Desai, Nileesa Gautam, et al.
Therapeutic Innovation & Regulatory Science|October 27, 2023
Safety of Intravenous Pantoprazole Sodium in Pediatric Patients Aged 1 Month to < 1 Year: A Real-World Retrospective Cohort StudySampada Gandhi, Benjamin Taylor, Lexie Rubens, et al.
BMJ Paediatrics Open|January 16, 2026
Safety of intravenous pantoprazole sodium in paediatric patients aged 1 year to <2 years: a real-world retrospective cohort study in the USASampada K Gandhi, Benjamin Taylor, Lexie Rubens, et al.
Pharmacoepidemiology and Drug Safety|December 15, 2021
Accuracy of identifying diagnosis of moderate to severe chronic kidney disease in administrative claims dataJulie M Paik, Elisabetta Patorno, Min Zhuo, et al.
British Journal of Clinical Pharmacology|August 2, 2021
Regulatory authority and clinical acceptability: Physicians' responses to regulatory drug safety warningsAlice L Bhasale, Ameet Sarpatwari, Wendy Lipworth, et al.
BMJ (Clinical Research Ed.)|February 11, 2021
Association of first trimester prescription opioid use with congenital malformations in the offspring: population based cohort studyBrian T Bateman, Sonia Hernandez-Diaz, Loreen Straub, et al.
Clinical and Experimental Rheumatology|May 26, 2022
Risk of malignant melanoma and non-melanoma skin cancer in rheumatoid arthritis patients initiating methotrexate versus hydroxychloroquine: a cohort studyHemin Lee, Sarah K Chen, Nileesa Gautam, et al.
Circulation|December 17, 2020
Emulating Randomized Clinical Trials With Nonrandomized Real-World Evidence Studies: First Results From the RCT DUPLICATE InitiativeJessica M Franklin, Elisabetta Patorno, Rishi J Desai, et al.
Future Oncology (London, England)|April 23, 2026
Real-world treatment patterns and outcomes of patients with multiple myeloma initiating elranatamab: results from the ALTITUDE-1 and ALTITUDE-2 retrospective cohort studiesRahul Banerjee, Meera Mohan, Bhavesh Shah, et al.
Clinical Pharmacology and Therapeutics|November 21, 2022
The Aetion Coalition to Advance Real-World Evidence through Randomized Controlled Trial Emulation Initiative: OncologyDavid Merola, Ulka Campbell, Nileesa Gautam, et al.
Pageof 2